CCR3 seems to be a target for asthma and allergy, but ongoing studies present a potential role of CCR3 antagonism in two disorders associated with the aging population, such as macular degeneration (MAD) and cognitive dysfunction in mice models [37]. Here, CCR3 is linked to asthma.